作者：
Stefan,Gröschel [1]
;
Martin,Bommer [2]
;
Barbara,Hutter [3]
;
Jan,Budczies [4]
;
David,Bonekamp [5]
;
Christoph,Heining [1]
;
Peter,Horak [1]
;
Martina,Fröhlich [3]
;
Sebastian,Uhrig [3]
;
Daniel,Hübschmann [6]
;
Christina,Geörg [7]
;
Daniela,Richter [8]
;
Nicole,Pfarr [9]
;
Katrin,Pfütze [7]
;
Stephan,Wolf [10]
;
Peter,Schirmacher [11]
;
Dirk,Jäger [12]
;
Christof,von Kalle [13]
;
Benedikt,Brors [3]
;
Hanno,Glimm [1]
;
Wilko,Weichert [14]
;
Albrecht,Stenzinger [15]
;
Stefan,Fröhling [1]
作者单位：
Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany;; Section for Personalized Oncology, Heidelberg University Hospital, Heidelberg 69120, Germany;; German Cancer Consortium (DKTK), Heidelberg 69120, Germany.
[1]
Klinikum am Eichert, Department of Hematology, Oncology and Infectious Diseases, Göppingen 73035, Germany.
[2]
German Cancer Consortium (DKTK), Heidelberg 69120, Germany;; Division Applied Bioinformatics, DKFZ and NCT Heidelberg, Heidelberg 69120, Germany.
[3]
Institute of Pathology, Charité University Hospital, Berlin 10117, Germany;; DKTK, Berlin 10117, Germany.
[4]
Department of Radiology, DKFZ, Heidelberg 69120, Germany.
[5]
Division of Theoretical Bioinformatics, DKFZ, Heidelberg 69120, Germany;; Department for Bioinformatics and Functional Genomics, Institute for Pharmacy and Molecular Biotechnology and BioQuant, Heidelberg University, Heidelberg 69120, Germany;; Department of Pediatric Immunology, Hematology and Oncology, Heidelberg University Hospital, Heidelberg 69120, Germany.
[6]
Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany;; German Cancer Consortium (DKTK), Heidelberg 69120, Germany;; DKFZ, Heidelberg Center for Personalized Oncology (HIPO), Heidelberg 69120, Germany.
[7]
Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany;; German Cancer Consortium (DKTK), Heidelberg 69120, Germany.
[8]
Institute of Pathology, Klinikum rechts der Isar, Technische Universität München, Munich 81675, Germany.
[9]
German Cancer Consortium (DKTK), Heidelberg 69120, Germany;; Genomics and Proteomics Core Facility, High Throughput Sequencing Unit, DKFZ, Heidelberg 69120, Germany.
[10]
German Cancer Consortium (DKTK), Heidelberg 69120, Germany;; Institute of Pathology, Heidelberg University Hospital and NCT Heidelberg, Heidelberg 69120, Germany.
[11]
Department of Medical Oncology, NCT Heidelberg, Heidelberg University Hospital, Heidelberg 69120, Germany.
[12]
Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany;; Section for Personalized Oncology, Heidelberg University Hospital, Heidelberg 69120, Germany;; German Cancer Consortium (DKTK), Heidelberg 69120, Germany;; DKFZ, Heidelberg Center for Personalized Oncology (HIPO), Heidelberg 69120, Germany.
[13]
Institute of Pathology, Klinikum rechts der Isar, Technische Universität München, Munich 81675, Germany;; DKTK, Munich 80539, Germany.
[14]
Institute of Pathology, Heidelberg University Hospital and NCT Heidelberg, Heidelberg 69120, Germany;; Department of Pathology, Center for Integrated Diagnostics, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
[15]
DOI
10.1101/mcs.a001180
PMID
27900363
发布时间
2022-04-08
换一批
换一批
